ClinConnect ClinConnect Logo
Search / Trial NCT06675786

The Effect of Catheter Protector on Catheter Dwell Time and Complications

Launched by KARAMANOĞLU MEHMETBEY UNIVERSITY · Nov 4, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Peripheral Venous Catheterization Iv House Complication Phlebitis

ClinConnect Summary

This clinical trial is looking at whether using a special protective cover, called the IV House Ultradressing, can help patients keep their peripheral venous catheters (PVCs) in place longer and reduce complications. PVCs are thin tubes inserted into a vein, often used for patients receiving treatment in an oncology clinic. The study will compare two groups of patients: one group will have the protective cover on their catheter, while the other group will not. Researchers want to find out if the cover makes a difference in how long the catheter can stay in without issues.

To participate in this trial, patients must be between 18 and 65 years old, currently hospitalized in the oncology clinic, and able to communicate without problems. They should also have a specific size catheter inserted and not have any skin issues at the catheter site. Throughout the study, participants will have their catheter monitored for how long it stays in place and any complications that may arise. It's important to note that this trial is not yet recruiting participants, so those interested will need to wait for it to begin.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion Criteria
  • Hospitalized in the oncology clinic
  • The one with the PVK attached,
  • Volunteered to participate in the research,
  • Treated in the same clinic during the study period,
  • No verbal, perceptual and visual communication problems,
  • 22-24 G (Blue) size catheter used,
  • Between the ages of 18 and 65,
  • Literate,
  • Patients without scar tissue, infection, hematoma, edema at the sites to be used for PVK placement were included in the study.
  • Exclusion Criteria:
  • - With a clotting disorder,
  • Patients with problems with skin integrity or limb movement such as scar tissue, infection, hematoma, edema at the PVK site,
  • Blood or blood products given through a catheter,
  • Patients who wanted to leave, were referred to a different clinic or discharged during the study were excluded from the study.

About Karamanoğlu Mehmetbey University

Karamanoğlu Mehmetbey University is a distinguished academic institution engaged in advancing medical research and clinical trials aimed at improving healthcare outcomes. With a commitment to fostering innovation and education, the university collaborates with a diverse range of healthcare professionals and researchers to explore new therapeutic strategies and enhance patient care. Its clinical trial initiatives are designed to generate robust scientific evidence, contributing to the global body of knowledge in medicine and supporting the development of effective treatments. Through a rigorous ethical framework and adherence to regulatory standards, Karamanoğlu Mehmetbey University seeks to make meaningful contributions to the field of clinical research and public health.

Locations

Patients applied

0 patients applied

Trial Officials

BETÜL TOSUN, DOÇ. DR.

Principal Investigator

Karamanoğlu Mehmetbey University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported